Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-005789

Options or other derivatives

  • CHIEF FINANCIAL OFFICER acquired 49,050 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ragosa Mark CHIEF FINANCIAL OFFICER 2023-04-01 Grant or award · Share Option +42,050 42,050 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2023-04-01 Grant or award · Restricted Share Unit +7,000 7,000 D
Loading xslF345X04/form4-04032023_040415.xml…